Evidence map›Paper›PMID 37441428›Full record

ArticleFrontiers in oncology2023

Corrigendum: Advanced NSCLC patients with EGFR T790M harbouring TP53 R273C or KRAS G12V cannot benefit from osimertinib based on a clinical multicentre study by tissue and liquid biopsy.

Yulong Fu, Anqi Wang, Jieqi Zhou, Wei Feng, Minhua Shi, Xiao Xu, Hongqing Zhao, Liming Cai, Jian Feng, Xuedong Lv and 10 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 15 institutions in 1 country.

Yulong FuDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
Anqi WangDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jieqi ZhouDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
Wei FengDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
Minhua ShiDepartment of Respiratory Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Xiao XuDepartment of Respiratory Medicine, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Hongqing ZhaoDepartment of Respirology, Nanjing Medical University Affiliated Wuxi Second Hospital, Wuxi, China.
Liming CaiDepartment of Respiratory Medicine, Affiliated Hospital of Jiangnan University, Wuxi, China.
Jian FengDepartment of Respiratory Medicine, Affiliated Hospital of Nantong University, Nantong, China.
Xuedong LvDepartment of Respiratory Medicine, The Second Affiliated Hospital of Nantong University, Nantong, China.
Xiaodong ZhangDepartment of Medical Oncology, Nantong Tumor Hospital, Nantong, China.
Wenjing XuDepartments of Respiratory Medicine, Northern Jiangsu People's Hospital, Clinical Medical College of Yangzhou University, Yangzhou, China.
Zhengrong ZhangDepartment of Respiratory Medicine, First People's Hospital of Yangzhou City, Yangzhou, China.
Guoer MaDepartment of Respiratory Medicine, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Jian WangDepartment of Respiratory Medicine, Zhenjiang First People's Hospital, Zhenjiang, China.
Tong ZhouDepartment of Oncology, Changzhou Cancer Hospital Affiliated to Soochow University, Changzhou, China.
Dahai ZhaoDepartment of Respiratory and Critical Care Medicine, The Second Hospital of Anhui Medical University, Hefei, China.
Haohui FangDepartment of Respiratory Medicine, Anhui Chest Hospital, Hefei, China.
Zeyi LiuDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jian-An HuangDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China.
First Affiliated Hospital of Soochow University · CNSoochow University · CNAffiliated Hospital of Nantong University · CNAffiliated Hospital of Jiangsu University · CNAnhui Medical University · CNCentral People's Hospital of Zhanjiang · CNJiangnan University · CNNanjing Medical University · CNNantong Tumor Hospital · CNNorthern Jiangsu People's Hospital · CNPeople's Hospital of Yangzhong · CNSecond Affiliated Hospital of Soochow University · CNSecond Hospital of Shanxi Medical University · CNSuzhou Research Institute · CNXi'an Chest Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2021.621992.].

Indexed as

drug resistanceepidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)gene sequencingliquid biopsynon-small cell lung cancer

Identifiers

PMID37441428
PMCPMC10335792
OpenAlexW4382317778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.